Transparency in pricing for patients and members of the public is desirable and empowers individuals to make informed decisions about their care, and the Council of the Pharmaceutical Society of Ireland (PSI) has previously published information on pricing transparency, available on its website.
In April 2025 I requested the PSI to consider the development of appropriate guidelines so that patients have an improved understanding of the fees that they pay in respect of the products they are dispensed and the services they use in pharmacies.
The PSI is scheduled to consider proposed draft guidance on Pricing Transparency at its upcoming meeting on the 26 June 2025, with a view to subsequently issuing this for public consultation prior to formal approval at the next subsequent meeting.